The nation of Zimbabwe has rejected a substantial US healthcare agreement worth $367m (272 million pounds) over five years due to the United States' request for sensitive biological samples.
This move was revealed following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "skewed".
A government representative has since stated that the US was seeking genetic material for scientific study and profit but was not willing to share the resulting advantages from future vaccines.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further talks to secure a agreement suitable to all parties so the country's critical HIV programme can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable case in Kenya, where a court blocked a related deal with the US after legal challenges were raised about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and accountability.
As per statements, 16 African countries have to date signed similar health pacts, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation could have provided immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Our nation was requested to provide its genetic material and health information indefinitely, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Put simply, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our people if a new pandemic arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to continued dialogue with our US partners on how future co-operation might be arranged in a way that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations need to persist given that much of the nation's Aids initiatives relied on international support.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.
The situation underscores the continuing challenges between receiving much-needed international aid and protecting national sovereignty in an increasingly interconnected world.